Monoclonal Antibodies to Disrupt Progression of Early Covid-19 Infection

Abstract

By the end of 2020, more than 19 million Americans had received the diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.1 Although a substantial proportion of these ...